VAB-3 combination chemotherapy of metastatic testicular cancer.

Abstract:

:The initial response and long-term follow-up of 74 evaluable patients who received combination chemotherapy for metastatic nonseminomatous testicular cancer are reported. Patients were treated with a protocol (VAB-3) including vinblastine, actinomycin-D, bleomycin, and cis-dichlorodiammine platinum (DDP). VAB-3 alone caused complete remission (CR) in 54% (40/74) and partial remission (PR) in 26% (1974). Five patients with less than CR to chemotherapy achieved CR following surgical excision of residual mature teratoma after starting VAB-3 protocol, resulting in an overall CR rate of 61% (45/74). With a minimum follow-up of 24+ months, and a median follow-up of 35+ months for those still living, 45% (33/74) of the patients are living free of evidence of disease, 4% (3/74) are living with disease, and 51% (38/74) are dead. Response to VAB-3 protocol was examined with respect to performance status, histology, prior therapy, extent of disease, tumor markers, and duration of disease from diagnosis. No one died because of toxicity of VAB-3, and life-threatening toxicity was uncommon. Long survival is significantly associated (P less than 0.001) with achievement of CR. The treatment goal for metastatic testicular cancer is cure. The achievement of CR, using aggressive combination chemotherapy and surgery, is essential in reaching this goal.

journal_name

Cancer

journal_title

Cancer

authors

Reynolds TF,Vugrin D,Cvitkovic E,Cheng E,Braun DW Jr,O'Hehir MA,Dukeman ME,Whitmore WF Jr,Golbey RB

doi

10.1002/1097-0142(19810815)48:4<888::aid-cncr28204

subject

Has Abstract

pub_date

1981-08-15 00:00:00

pages

888-98

issue

4

eissn

0008-543X

issn

1097-0142

journal_volume

48

pub_type

临床试验,杂志文章

相关文献

CANCER文献大全
  • Brain metastasis in the natural history of small-cell lung cancer: 1972-1979.

    abstract::The records of 134 patients with small-cell lung cancer who had been seen at Henry Ford Hospital between 1972-1979 were reviewed with emphasis on brain metastasis. Brain metastasis developed in 28% of the patients; 21% had brain metastasis at the time of diagnosis and in 7% it developed later (de novo). In 9%, the chi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820815)50:4<752::aid-cncr28205

    authors: Doyle TJ

    更新日期:1982-08-15 00:00:00

  • Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.

    abstract:BACKGROUND:The human papillomavirus (HPV) E2 protein is a transcriptional repressor of the oncogenes E6/E7 and loss of E2 function is considered a key step in carcinogenesis. Integration of HPV into the host genome may disrupt the E2 gene. Furthermore, methylation of CpG dinucleotides in E2-binding sites (E2BSs) in the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29315

    authors: Reuschenbach M,Huebbers CU,Prigge ES,Bermejo JL,Kalteis MS,Preuss SF,Seuthe IM,Kolligs J,Speel EJ,Olthof N,Kremer B,Wagner S,Klussmann JP,Vinokurova S,von Knebel Doeberitz M

    更新日期:2015-06-15 00:00:00

  • Intensity-modulated radiation therapy use in the U.S., 2004.

    abstract:BACKGROUND:Intensity-modulated radiation therapy (IMRT) is a novel approach to the planning and delivery of radiation therapy. The prevalence of IMRT use among radiation oncologists in the U.S. appears to be increasing, despite limited data evaluating its risks and benefits. METHODS:A random sample of radiation oncolo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21284

    authors: Mell LK,Mehrotra AK,Mundt AJ

    更新日期:2005-09-15 00:00:00

  • Consideration of comorbidity in risk stratification prior to prostate biopsy.

    abstract:BACKGROUND:Previously, the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-CaP) questionnaire and/or the physician-reported Charlson Comorbidity Index (CCI) have provided assessments of competing comorbidity during treatment decisions for patients with prostate cancer. In the current study, the au...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28044

    authors: Liss MA,Billimek J,Osann K,Cho J,Moskowitz R,Kaplan A,Szabo RJ,Kaplan SH,Greenfield S,Dash A

    更新日期:2013-07-01 00:00:00

  • A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.

    abstract::The clinical findings in 262 patients with melanoma were correlated with an assessment of their cellular-mediated immunity by delayed-type hypersensitivity (DTH) skin tests, by lymphocyte blastogenesis, and by leukocyte enumerations. Patients with systemic metastases (stage IV) and those with evidence of tumor burden ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197806)41:6<2165::aid-cncr282041

    authors: Pritchard DJ,Ritts RE Jr,Taylor WF,Miller GC

    更新日期:1978-06-01 00:00:00

  • The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.

    abstract::Carcinoembryonic antigen (CEA) values in 529 patients treated in two consecutive adjuvant chemotherapy protocols were analyzed to determine if CEA values correlated with disease-free status or prognostic utility. CEA values were evaluated preoperatively, before chemotherapy, at the conclusion of chemotherapy, and duri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890301)63:5<828::aid-cncr28206

    authors: Theriault RL,Hortobagyi GN,Fritsche HA,Frye D,Martinez R,Buzdar AU

    更新日期:1989-03-01 00:00:00

  • Patterns and predictors of colorectal cancer test use in the adult U.S. population.

    abstract:BACKGROUND:Screening is effective in reducing the incidence and mortality of colorectal cancer. Rates of colorectal cancer test use continue to be low. METHODS:The authors analyzed data from the National Health Interview Survey concerning the use of the home-administered fecal occult blood test (FOBT) and sigmoidoscop...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20276

    authors: Seeff LC,Nadel MR,Klabunde CN,Thompson T,Shapiro JA,Vernon SW,Coates RJ

    更新日期:2004-05-15 00:00:00

  • Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect.

    abstract:BACKGROUND:The authors have previously reported a tumor cell vaccine modified with superantigen staphylococcal enterotoxin A (SEA) and its antitumor effect. The tumor cell vaccines modified with multiple immune activators frequently elicited stronger immune responses against established tumors than single-modified vacc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20943

    authors: Yi P,Yu H,Ma W,Wang Q,Minev BR

    更新日期:2005-04-01 00:00:00

  • Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma.

    abstract:BACKGROUND:The current study evaluated the efficacy of a 10-week, group-based, cognitive-behavioral stress management (CBSM) intervention relative to a half-day seminar in improving quality of life (QoL) among men who were treated for localized prostate carcinoma (PC) with either radical prostatectomy (RP) or radiation...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/cncr.11894

    authors: Penedo FJ,Dahn JR,Molton I,Gonzalez JS,Kinsinger D,Roos BA,Carver CS,Schneiderman N,Antoni MH

    更新日期:2004-01-01 00:00:00

  • Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.

    abstract:BACKGROUND:To identify potential genetic markers for severe oxaliplatin-induced chronic peripheral neuropathy (OXCPN), the authors performed a genome-wide association analysis of patients with colon cancer who received oxaliplatin-based chemotherapy. METHODS:This was a prospective study in which DNA was purified in pe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26614

    authors: Won HH,Lee J,Park JO,Park YS,Lim HY,Kang WK,Kim JW,Lee SY,Park SH

    更新日期:2012-06-01 00:00:00

  • Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.

    abstract:BACKGROUND:A considerable body of evidence supports the concept that a significant number of cutaneous malignant melanomas progress through a precursor lesion or dysplastic melanocytic nevi (DN). Tumor angiogenesis likely plays a critical role in early development of melanoma, and intermediate biomarkers of angiogenesi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23076

    authors: Einspahr JG,Thomas TL,Saboda K,Nickolof BJ,Warneke J,Curiel-Lewandrowski C,Ranger-Moore J,Duckett L,Bangert J,Fruehauf JP,Alberts DS

    更新日期:2007-12-01 00:00:00

  • Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast.

    abstract::Estrogen receptors in breast tumors were assayed in 55 premenopausal women undergoing bilateral oophorectomy and in 120 postmenopausal women undergoing bilateral adrenalectomy for treatment of metastatic breast cancer. The data show that 20 (60%) of the 32 patients with estrogen receptor-positive (ER+) tumors had obje...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801215)46:12+<2779::aid-cncr28

    authors: Dao TL,Nemoto T

    更新日期:1980-12-15 00:00:00

  • Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature.

    abstract:BACKGROUND:The outcome of surgical treatment for early gastric cancer (EGC) generally is considered to be satisfactory. Although a small percentage of patients experience disease recurrence, the absolute number of such instances is too small for assessment of risk factors. METHODS:The authors investigated the follow-u...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19931201)72:11<3174::aid-cncr282

    authors: Sano T,Sasako M,Kinoshita T,Maruyama K

    更新日期:1993-12-01 00:00:00

  • Quality assurance for interventions in clinical trials. Multicenter data monitoring, data management, and analysis.

    abstract::Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow-up as well as trial end points direct the selection of appropriate compliance measures. To integrate th...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19941101)74:9+<2647::aid-cncr282

    authors: Pollock BH

    更新日期:1994-11-01 00:00:00

  • Establishment of three bleomycin-resistant human carcinoma cell lines and their cross-resistance to other antitumor agents.

    abstract::Three bleomycin-resistant (BLMr) human carcinoma cell lines (HeLa-BLMr, KB-BLMr, and Hepd-uvBLMr) were established in culture by progressively increasing the concentration of bleomycin (BLM). HeLa-BLMr and KB-BLMr were obtained after 5 and 2 months of incubation with BLM, whereas the establishment of Hepd-uvBLMr requi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880415)61:8<1501::aid-cncr2820

    authors: Urade M,Sugi M,Miyazaki T

    更新日期:1988-04-15 00:00:00

  • Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases.

    abstract::A 30-year Memorial Hospital experience with 146 patients with malignant mixed tumor is reviewed. These comprised 5% of 2,743 patients who were treated for salivary neoplasms from 1939 through 1968. The tumors arose in the parotid gland in 108 patients, submaxillary gland in 23 patients, mucus or so-called minor saliva...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197702)39:2<388::aid-cncr2820390

    authors: Spiro RH,Huvos AG,Strong EW

    更新日期:1977-02-01 00:00:00

  • Cytology of myoepithelial carcinoma of the salivary gland.

    abstract:BACKGROUND:Myoepithelial carcinoma, also know as malignant myoepithelioma, is rare in the salivary gland, and its cytologic features have rarely been reported. DESIGN:Four cases of myoepithelial carcinoma with cytology were retrieved from the archives of the Pathology Departments of two academic institutes. In three c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Chhieng DC,Paulino AF

    更新日期:2002-02-25 00:00:00

  • Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.

    abstract:BACKGROUND:Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance status (PS). However, the benefit of ICIs for patients with a poor PS remains unknown. It was hypothesized that a poor Eastern Cooperative Oncology Group (ECOG) PS (≥...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.32645

    authors: Khaki AR,Li A,Diamantopoulos LN,Bilen MA,Santos V,Esther J,Morales-Barrera R,Devitt M,Nelson A,Hoimes CJ,Shreck E,Assi H,Gartrell BA,Sankin A,Rodriguez-Vida A,Lythgoe M,Pinato DJ,Drakaki A,Joshi M,Isaacsson Velho P

    更新日期:2020-03-15 00:00:00

  • Validation of a multidimensional evaluation scale for use in elderly cancer patients.

    abstract:BACKGROUND:Although aging is one of the most important risk factors for cancer, elderly patients tend to be excluded from cancer clinical trials, only on the basis of chronologic age. Performance Status (PS) has been used widely to select adult patients for entry into clinical trials, but it does not include a comprehe...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(SICI)1097-0142(19960115)77:2<395::AID-CNC

    authors: Monfardini S,Ferrucci L,Fratino L,del Lungo I,Serraino D,Zagonel V

    更新日期:1996-01-15 00:00:00

  • High-risk groups of patients with Stage II colon carcinoma.

    abstract:BACKGROUND:It is unclear whether patients with Stage II colon carcinoma should be offered adjuvant chemotherapy. Therefore, the authors analyzed the risk factors of these patients to identify high-risk subgroups who may benefit from such treatment. METHODS:The data from 305 patients with Stage II colon carcinoma docum...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20010915)92:6<1435::aid-cncr1467

    authors: Merkel S,Wein A,Günther K,Papadopoulos T,Hohenberger W,Hermanek P

    更新日期:2001-09-15 00:00:00

  • Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels.

    abstract:BACKGROUND:The current study was performed to evaluate prognostic factors for overall survival (OS), distant metastasis (DM), and local failure (LF) in patients with Stage II/III esophageal carcinoma. METHODS:The following potential prognostic factors were retrospectively investigated in 124 patients treated with radi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20952

    authors: Rades D,Schild SE,Bahrehmand R,Zschenker O,Alberti WA,Rudat VR

    更新日期:2005-04-15 00:00:00

  • Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer.

    abstract::Data from a hospital-based case-control study between 1985-1990 were used to examine the effects of tobacco, alcohol, asbestos, and other occupational exposures on laryngeal cancer risk in 194 white men with primary cancer of the larynx and 184 age-matched control subjects. A dose-dependent effect for current cigarett...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920501)69:9<2244::aid-cncr2820

    authors: Muscat JE,Wynder EL

    更新日期:1992-05-01 00:00:00

  • Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.

    abstract:BACKGROUND:Adenoid cystic carcinoma (ACC) of the head and neck (ACCHN) is a rare tumor of minor salivary, parotid, and submandibular glands. The biologic behavior of the disease is poorly understood, and nonsurgical treatment strategies have yet to be standardized. The long-term prognosis continues to be guarded, with ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27408

    authors: Ellington CL,Goodman M,Kono SA,Grist W,Wadsworth T,Chen AY,Owonikoko T,Ramalingam S,Shin DM,Khuri FR,Beitler JJ,Saba NF

    更新日期:2012-09-15 00:00:00

  • Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy.

    abstract::A retrospective study was done of all patients who were seen for definitive treatment of adenocarcinoma of the pancreas at the Massachusetts General Hospital from 1963 to 1973. There were a total of 145 patients. Thirty-one patients were treated with radical surgery, with a 16% operative mortality, a 5-year crude surv...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197603)37:3<1519::aid-cncr282037

    authors: Tepper J,Nardi G,Sutt H

    更新日期:1976-03-01 00:00:00

  • Quality of life of African-American and white long term breast carcinoma survivors.

    abstract:BACKGROUND:Increasingly, the quality of life (QOL) of women diagnosed with breast carcinoma is being studied. However, there is little information regarding long term survivors among ethnic minority women. The purpose of this study was to describe the QOL of long term breast carcinoma survivors (BCS) and to examine the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19990115)85:2<418::aid-cnc

    authors: Ashing-Giwa K,Ganz PA,Petersen L

    更新日期:1999-01-15 00:00:00

  • Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma.

    abstract:BACKGROUND:Recently, the authors identified molecular signatures and pathways associated with nonsmall cell lung carcinoma histology and lung development. They hypothesized that genetic classifiers of histology would provide insight into lung tumorigenesis and would be associated with clinical outcome when evaluated in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20542

    authors: Shah L,Walter KL,Borczuk AC,Kawut SM,Sonett JR,Gorenstein LA,Ginsburg ME,Steinglass KM,Powell CA

    更新日期:2004-10-01 00:00:00

  • Peripheral B- and T-lymphocyte counts in patients with sarcoma and breast carcinoma.

    abstract::Peripheral B- and T-lymphocyte counts were studied in 50 patients before they received any therapy for their conditions: 16 had carcinoma of the breast; 8 soft tissue sarcoma; and 26, benign disease. Among 11 males, the six patients with advanced soft tissue sarcoma had significantly lower percentages of T lymphocytes...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197708)40:2<667::aid-cncr2820400

    authors: Lee YT,Marshall GJ,Weiner J,Bateman JR

    更新日期:1977-08-01 00:00:00

  • Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.

    abstract::The role of amsacrine in inducing remission in patients with cardiac disease and acute leukemia was evaluated. There were 17 patients with acute myelogenous leukemia (AML), six with acute lymphocytic leukemia (ALL), and one with biphenotypic leukemia. In this series of 24 patients whose disease had relapsed and who ha...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910915)68:6<1198::aid-cncr2820

    authors: Arlin ZA,Feldman EJ,Mittelman A,Ahmed T,Puccio C,Chun HG,Cook P,Baskind P,Marboe C,Mehta R

    更新日期:1991-09-15 00:00:00

  • Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program.

    abstract::To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Institute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982, 462 patients with resectable Stage III or IV canc...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19870801)60:3<301::aid-cncr28206

    authors:

    更新日期:1987-08-01 00:00:00

  • Glomangioma of the trachea.

    abstract::A case of a glomus tumor arising in an unusual site, the trachea, is described. The tumor was composed of a mixture of glomus cells and mast cells. At the ultrastructural level, the glomus cells exhibited features of modified smooth-muscle cells. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800501)45:9<2337::aid-cncr2820

    authors: Fabich DR,Hafez GR

    更新日期:1980-05-01 00:00:00